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Implication for health policy/practice/research/medical education:
Holarrhena floribunda trunk bark exhibited antihypertensive and antioxidant properties, supporting its use for the treatment of 
hypertension in traditional medicine. So, more investigations are needed for identification of the active compounds in Holarrhena 
floribunda ethanolic extract involved in antioxidant and antihypertensive activities.
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Introduction: Holarrhena floribunda (G.Don) T.Durand & Schinz is a tree that can grow up 
to 25 m with white latex in its organs. The bark of this plant is commonly used in traditional 
medicine to treat dysentery, diarrhea, diabetes, malaria, and high blood pressure. In this 
study, phytochemical groups were widely investigated on trunk bark as well as on leaves of H. 
floribunda harvested in Danyi (Togo). Antioxidant activity and antihypertensive properties 
of the plant extracts were also evaluated on sound guinea pigs.
Methods: The hydro-ethanolic extract of the trunk bark was prepared and antioxidant activity 
was evaluated via the DPPH radical-scavenging and the ferric-reducing antioxidant power 
(FRAP) methods, and via the determination of the total phenolics content. This hydro-ethanolic 
extract was used to assess the plant extract effect on blood pressure of sound guinea pigs. 
Results: So, phytochemical screening revealed that H. floribunda contained most of the 
phytochemical groups. The 50% inhibitive concentration of that extract by DPPH was 29.80 
± 0.001 μg/mL. The equivalent of Fe2+ by FRAP was 1009.9 ± 0.6 μmol/g of dry extract. The 
content of phenolic compounds was 139 ± 0.053 mg GAE (gallic acid equivalents)/g of dry 
extract. Intravenous injection of the extract (10, 20, 40, 80 mg/kg) via the invasive method in 
guinea pigs under normal strain caused a decrease in diastolic blood pressure, systolic blood 
pressure, and so in mean arterial pressure (MAP) by dose cumulative and time-dependent. 
Conclusion: The results show that hydro-ethanolic extract of H. floribunda trunk bark has 
antihypertensive and antioxidant properties. This might be the reason for the use of that extract 
for the treatment of hypertension in traditional medicine.
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A B S T R A C T
Introduction
Cardiovascular diseases (CVD) are pathologies that affect 
the heart and blood vessels. They are the main cause of 
deaths in the world (1). More than three-quarters of 
deaths in low- and middle-income countries are due to 
CVD (2). In Togo, the situation of CVD is of great concern 
while their incidence is not fully known (3). Risk factors 
for CVD include poor nutrition and physical inactivity, 
smoking, oxidative stress, heavy drinking, diabetes, 
hyperlipidemia, and hypertension. Indeed, hypertension 
is a chronic pathology that constitutes a real public health 
problem with a global prevalence in the world for adults 
estimated at 26.4% in 2000 (972 million people including 
639 million in resource-limited countries) and could reach 
29% by 2025 (1.56 billion of peoples) (4). The conventional 
treatments of hypertension require synergy of several 
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classes of antihypertensive agents; even so none of those 
treatments definitely cured this pathology. Moreover, the 
high cost when facing the treatment of hypertension with 
conventional drugs makes it hardly affordable for common 
peoples. For that, common people prefer using traditional 
medicines. Indeed, some studies have shown the positive 
effects of antioxidants from plants as good agents for the 
prevention of hypertension diseases (5). It is known that 
several plants are used in traditional medicine to treat 
high blood pressure (6). Holarrhena floribunda is one of 
those species which natural ecological zone covers many 
African countries namely Togo, Senegal, Guinea-Bisseau, 
Guinea, Mali; Burkina Faso, Sierra Leonne, Liberia, Ivory 
Coast, Ghana, Benin, Nigeria, Chad, Cameroon, Gabon, 
Congo, Central Africa. The many uses of H. floribunda 
in traditional medicine in those African countries include 
the treatment of dysentery, diarrhea, fever, snake bite, 
infertility, venereal disease, diabetes, hypertension, and 
malaria (7,8). So, the present study aimed mainly the 
assessment of the antihypertensive effects of the ethanolic 
extract of the trunk bark of H. floribunda. For that, the 
phytochemical groups of the leaves and the trunk bark 
were firstly investigated. Then, the anti-radical activity 
and the effect on the blood pressure of normal strained 
guinea pigs of the trunk bark hydro-ethanolic extract were 
evaluated.
Materials and Methods
General information
Optical densities (absorption spectra) were determined 
on a Shimadzu UV-1601PC spectrophotometer. Samples 
were weighted using a Sartorius lab instruments balance 
with maximum weight of 1000 ± 0.01 g. Evaporation 
was carried out on an R-100 BÜCHI Rotavapor. An 
electric shredder and a transducer connected to Biopac 
System (Model MP100, Harvard Apparatus) allowed the 
assessment of extract effects on sound guinea pigs blood 
pressure. Analytical grade solvents and all others materials 
were used as received.
Phyto-constituents characterization
Phytochemical screening refers to all methods and 
techniques for the detection of active chemical groups 
in the plant. In this study, the whole phytochemical 
screening was performed according to standard methods 
described by Badiaga et al (9). So, the presence of alkaloids 
has been revealed by Mayer or Dragendorff ’s reagent. 
STIANSY reagent or 1% ferric chloride was used to 
characterize tannin derivatives. Flavonoids derivatives 
and buffy anthocyanins were evidenced by the cyanidine 
reaction (SHINODA reagent). Quinone compounds were 
evidenced by the Bornträger reaction. The detection of 
sterols and triterpenes were possible with Liebermann-
Burchard reaction. Cardiotonic glycosides were revealed 
when green or purple color came out after adding the 
acetic and sulfuric acid in chloroformic extract. The 
appearance of a flaky precipitate revealed the presence 
of mucilages. Saponosides were characterized by their 
foaming power. Reducing constituents were characterized 
using A and B Fehling liquors. The anthracites derivatives 
were revealed using a 50% ammonia solution. 
Biological materials
The bark of the trunk and the leaves of H. floribunda 
were harvested in March 2015 at Danyi Mountain in the 
plateaus region (Zone IV) of Togo. The plant is locally 
called “Afèkèti” or “Kpomiti” in “Ewé”. It was (the plant 
species) identified by the Herbarium of “Université de 
Lomé” (TOGO; TOGO02074) and previously registered 
under the identification number 1987/03 by K. Akpagana 
(K. Akpagana, #1522). The plant samples were left at room 
temperature for two weeks. After this drying process, the 
samples were reduced in powder using a lab scale grinder. 
Hydro-ethanolic extract of the trunk was prepared to 
assess pharmacological effects of H. floribunda on guinea 
pigs under normal blood pressure (systolic blood pressure 
≤120 mm Hg) weighting about 400-550 g. They were 
bought in Gbonsimé market in Lomé city (Togo) and 
placed at animal house of the Laboratory of physiology 
and pharmacology of natural products of the Faculty of 
Sciences, “Université de Lomé” (Togo), for a week before 
the experiments. These guinea-pigs had free access to 
water and were fed with fresh grass. 
Cardiovascular effects assessment via bloody method
The so-called direct bloody method is an invasive 
technique for measuring blood pressure using a catheter 
introduced into the carotid artery of an anesthetized animal 
(10). The measurement of invasive pressure presents some 
advantages, notably the beat-by-beat tracking of blood 
pressure and the achievement of a very precise pressure 
even at very low extent. The invasive pressure was 
measured using a transducer (connected to the catheter) 
with an ultra-sensitive membrane capable of converting 
the slightest mechanical variations of the animal’s blood 
pressure into electrical signals. The recording of the 
cardiovascular parameters was done according to this 
method exhaustively described previously (11). The 
guinea pig, anesthetized intraperitoneally with 20% of 
urethane (ethyl carbamate) at a dose of 1 g/kg (that is 1 
mL/200 g body weight), was placed in supine position 
(12). The jugular vein and the carotid artery were exposed, 
dissected, and then intubated towards the heart using fine 
polyethylene catheters. 
The catheter of the jugular vein connected to one syringe 
and that of the carotid artery linked to a pressure sensor 
connected to a transducer were used to visualize the 
hemodynamic parameters such as the systolic blood 
pressure (SBP, mm Hg) and the diastolic blood pressure 
(DBP, mm Hg). Those two types of blood pressure 
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correspond to the maximum and the minimum pressures, 
respectively. Mean arterial pressure (MAP, mmHg) does 
not an arithmetic average of SBP and DBP, because blood 
pressure values in the arteries are more closed to DBP 
value for a long time. For that, the average pressure was 
obtained from the following stated Pelletier’ relation (13):
( )
3
SBP DBPMAP DBP −= +
After stabilization of the cardiovascular parameters 
for about 45 minutes, the extracts of H. floribunda at 
cumulative doses of 10; 20; 40; 80 mg/kg (taking into 
account the toxicity studies of H. floribunda by Bogne et 
al (14) and Antwi (15)) were administered intravenously 
through the syringe connected to catheter of the jugular 
vein of a guinea pig under normal blood pressure. The 
NaCl solution (9‰) containing 10% of heparin was 
injected at a rate of 1 mL/1000 g via this jugular vein to 
prevent blood from clotting. The decrease rate in MAP 
was calculated using the following relation:
% Δ MAP = ((MAPi - MAPf) × 100) / (MAPi)
With i = initial; f = final
Determination of total phenols and polyphenolic 
antioxidants
The determination of total phenols content is an in vitro 
colorimetric assay based on the ability to reduce the 
Folin-Ciocalteu reagent (FCR) (16) which is a yellow 
acid solution consisting of a mixture of phosphotungstic 
and phosphomolybdic polyheterocyclic acids. In a 
basic medium, the FCR oxidizes the hydroxyl groups of 
polyphenolic compounds giving a blue coloration. This 
determination was carried out according to the method 
described by Al-Farsi et al (17). A mixture consisting of 
100 μL of extract in methanol at 1 mg/mL and 750 μL of 
the FCR 10 times diluted was prepared. After stirring for 5 
minutes, 750 μL of a saturated sodium carbonate (Na2CO3) 
solution at 60 g/L was added. The obtained solution was 
incubated for 90 minutes at room temperature in the 
darkness. The absorption spectra (optical densities) were 
recorded with respect to a blank at 725 nm using a UV-
visible spectrophotometer. Referring to the calibration 
regression equation established with gallic acid in a 
concentration range of 0-500 μg/mL (Figure 1), the 
content of polyphenols in the extract was determined. The 
test was performed in triplicate. The following formula 
was used to calculate the total phenol contents expressed 
in mg Equivalent of Gallic Acid (EGA) over 1 g of dry 
extract:
( )
Re . .
.
Polyphenol content EAG par g
c Conc Dil Fact Vo
sampl mass
=
× ×
Rec.Conc: recorded concentration; Dil.Fac: dilution factor; 
Vo: initial volume; Sampl.mass: masse of the sample.
Free DPPH• radical trapping activity
The antiradical activity was determined using the method 
described by Brand-Williams et al (18), modified by 
Agbonon et al (19). This method relies on the trapping of 
the stable free radical DPPH in the presence of antioxidant 
molecules.
The DPPH solution of about 10-4 mol/L was prepared 
(about 1 to 2 hours in advance) by making soluble the pure 
DPPH in methanol so that the solution exhibited an optical 
density between 0.787 and 0.788 at 517 nm. A range of 
concentrations (1 to 50 μg/mL) of H. floribunda extract or 
quercetin solutions was prepared in methanol. A volume 
of 250 μL of each of those prepared solutions was added to 
1.5 mL of the DPPH solution (C = 10-4 mol/L), the mixture 
was homogenized and incubated at room temperature for 
30 minutes. The optical density was then recorded at 517 
nm using a UV-visible spectrophotometer. The control 
was recorded under the same conditions. The inhibition 
percent (%I) of the DPPH was calculated according to the 
following formula:
% 100 ODc ODsI
ODc
−
= ×
ODc: Optical Density of the control; OD: Optical Density 
of the sample (extract or quercetin).
The anti-radical power was defined as the concentration 
of extract needed to induce the reduction of 50% of the 
free radical DPPH (IC50). The IC50 value was calculated 
by the linear regression method shown in Figure 2: %I = 
f (concentration) = ax + b, with a and b constants and x 
a concentration; %I = 50% = f (IC50). Standard deviations 
were calculated from three sets of experiments. The IC50 
value depends on the nature of the sample and the final 
residual concentration of the DPPH.
Antioxidant power by the FRAP
The ferric ion reducing antioxidant power (FRAP) 
method consists of reducing ferric ions from the ferric 
tripyridyltriazine complex (Fe3+-TPTZ) to ferrous ions 
under a low pH and temperature of about 37°C. The 
change in absorbance at 593 nm is directly associated with 
Figure 1. Calibration graph of gallic acid.
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the combined reducing power of all antioxidant molecules 
present in the reaction mixture (20).
For that, freshly prepared 1980 μL FRAP solution 
consisting of 25 mL acetate buffer (pH = 3.6), 2.5 mL 
TPTZ at 10 mmol/L in HCl 40 mmol/L, and 2.5 mL of 
FeCl3.6H2O at 20 mmol/L, was added to 15 μL of the 
extract solution. The optical densities of samples and 
blank at 593 nm were recorded using a UV-visible 
spectrophotometer. A calibration range was established 
from different concentrations (0 to 2000 μmol/L) of 
FeSO4.7H2O in methanol. Referring to the regression 
equation of the calibration established with FeSO4.7H2O 
(Figure 3), the content of polyphenols in the extract was 
determined and expressed in μmol of Fe2+ equivalent 
per gram of extract. The test was performed in triplicate 
from which the standard deviations were calculated. 
The concentration (content of polyphenols) of the stock 
solution was obtained using the following formula:
2( )
.
. .
FRAP value mol equivalent Fe per g
R
Sampl M
ec Conc Dilut Fac Vo
s
t
a s
µ + =
× ×
Rec.Conc: recorded concentration; Dilut.Fact: dilution 
factor; Vo: volume of the stock solution; Sampl.mass: mass 
of the sample.
Statistical processing
Data were expressed as means ± standard deviation (SD) 
of experiments performed in triplicate or in quintuplicate 
according to the test. The values were analyzed by 
analysis of variance (ANOVA) test, followed by Tukey’s 
multiple comparison tests using GraphPad Prism 5.00. 
The statistical significance between results for different 
samples and between results for samples and controls 
were set at P < 0.05.
Results
Phytochemical screening of Holarrhena floribunda
In order to investigate the phytochemical composition 
of H. floribunda, infusion, maceration, and decoction 
were used and many extracts obtained. For that, the 
leaves and bark of trunk powder samples were firstly 
subjected to infusion and decoction. The similar powder 
Figure 2: a) Linear regression line of quercetin, b) Linear regression line of Holarrhena floribunda extract with DPPH
Figure 3. Calibration curve of FeSO4.7H2O
samples were then macerated in many organic solvents 
(ethanol, chloroform, hydrochloric acid, ethyl acetate, 
and petroleum ether). The various phytochemical groups 
detected in infused and decocted samples are recorded on 
the Table 1, and those from the maceration are drawn up 
in Table 2. 
From infusion method (Table 1), one can see that 
anthocyanins were not detected. In the same time, tannins 
(catechics and gallic), saponosides, and flavonoids have 
been detected. From the decocted phases, the leuco-
anthocyanins, saponosides, mucilages, flavonoids, and 
reducing compounds were revealed in the two parts. 
Moreover, foam index performed on the decocted phase 
was 500 in the leaves against 333.33 in the trunk bark. 
In macerated samples and when using some specific tests, 
various phytochemical compounds were detected (Table 
2). So, only alkaloids and saponosides were detected in 
ethanol while cardiotonic heterosides, c-heteroside, and 
o-heteroside anthracenic were found in chloroformic 
macerated phases. Alkaloids were found in hydrochloric 
acid; sterols and terpenes in ethyl acetate, and free 
quinones in petroleum.
Anti-radical activity by DPPH, antioxidant power by 
FRAP and total phenol content 
Based on the calibration regression equation established 
in Figure 1, the total phenol content (in equivalent of 
gallic acid per gram of dry extract) of the trunk bark 
hydro-ethanolic extract was 139±0.053 mg EGA/g dry 
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extract. The antioxidant activity of the same extract was 
evaluated by the DPPH and the FRAP methods. The 
DPPH test allows getting the anti-radical activity. Indeed, 
it is known that an extract is more antioxidant if its IC50 is 
lower. From Table 3, the IC50 of this extract is 29.80±0.001 
μg/mL while that of quercetin is 11.19±0.23 μg/mL. The 
reducing power assessed by the FRAP method gave the 
value of 1009.9 ± 0.6 μmol Equivalent Fe2+/g (Table 3). 
Furthermore, the kinetics of the reduction of DPPH under 
different concentrations of the extract was monitored. As 
shown in Figure 4, the decrease in absorbance is more 
pronounced for large concentrated sample. The kinetic 
profiles are dependent on the concentration of the extract. 
Close observation shows that the extract reacted quickly 
with the DPPH reaching a steady state in about 5 minutes. 
Assessment of the extract effect on guinea-pigs blood 
pressure
Intravenous injection of the hydro-ethanolic extract (by 
cumulative dose in the order of 10; 20; 40; 80 mg/kg) 
Table 1. Chemical groups detected in infuse and decocted powders of the leaves and the bark of the trunk
Extraction method Phyto-constituents Leaves Trunk bark
Infusion Tannins + +
Catechic tanins + +
Gallic tannins + +
Saponosides + +
Flavonoids + +
Anthocyanins - -
  Decoction Leuco-anthocyanins + +
Saponosides + +
Foam Index 500 333.33
Mucilages + +
Flavonoids + +
Reducing compounds + +
+: Detected; -: Not detected.
Table 2. Phyto-constituents from different macerated phases of leaves and trunk bark
Extraction method Phytoconstituents Leaves Bark of the trunk
Maceration in ethanol Alkaloids + +
Saponosides + +
Maceration in CHCl3 Cardiovascular heterosides + +
Free anthracenic - -
Anthra.O-heterosides + +
Anthra.C-heterosides + +
Maceration in HCl Alkaloids + +
Maceration in ethyl acetate Sterols and terpenes + +
Maceration in petroleum ether Free quinones + +
+: Detected; -: Not detected.
Table 3. Results of DPPH and FRAP tests
Sample IC50±SD (μg/mL) FRAP Equi.Fe2+ (μmol/g)
Extract 29.80±0.001 1009.9±0.6
Quercetin 11.19±0.23 -
Values are expressed as means ± standard deviation (SD) (n = 3).
Figure 4. Kinetics of the reduction of the DPPH alone (black), DPPH 
with 20 μg/mL of Holarrhena floribunda extract (red), and DPPH with 
30 μg/mL of Holarrhena floribunda extract (blue).
resulted in immediate decreases in mean arterial pressure 
(MAP) of normal strained guinea pigs (Figures 5 and 6). 
Indeed, a few seconds after injection of 10 mg/kg of the 
prepared dose, MAP decreased from 82.734 mm Hg to 
65.067 mm Hg, which is an immediate and significant 
decrease of about 21.35%. Then, the pressure rose to hit 
the initial value in about 10 minutes later. Administering 
the dose of 20 mg/kg resulted in a sharp and significant 
decrease in MAP of about 27.86%; 15 minutes later, the 
MAP rose and stabilized at about 70.6 mm Hg. The 40 
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mg/kg dose resulted in a sharp and significant decrease 
in MAP of about 36.41%; 20 minutes later the MAP rose 
and steadied at about 61.33 mm Hg. When 80 mg/kg was 
injected, a drastic and significant drop in MAP of about 
57.68% was observed, 20 minutes later, the MAP rose 
slowly and steadied at about 47.67 mm Hg. It should be 
noted that the physiological solution of NaCl 9% with 10% 
of heparin had no significant effect on MAP (a variation 
of 0.025% has been obtained).
Discussion
First of all, the results of phytochemical screening of 
the leaves and the trunk bark confirmed the previous 
works of Badmus et al (21) and of Gnangoran et al (22). 
Indeed, most of the metabolites found in the current 
study possess significant pharmacological properties, 
including analgesics, anesthetics, antibiotics, and anti-
cancer (23). For instance, plants containing flavonoids 
are known as potent antioxidants, antiradicals, diuretics, 
purgatives, disinfectants, analgesics, anti-inflammatories, 
antipyretics, and antispasmodics (24).
The revealed antioxidant properties (Table 3) of the hydro-
Figure 5. Effect of dose-response of Holarrhena floribunda 
extract on MAP.
Figure 6. a) MAP of normal guinea pigs development under NaCl 9‰ and doses of Holarrhena floribunda extract 15 minutes after injection; b) 
Impact of NaCl 9‰ and extract of Holarrina floribunda on fall in MAP of normal guinea pigs. Each point represents an average ± SD (standard 
deviation). With n = 5, *P < 0,05; **P < 0,01 and ***P < 0,001 significantly different compared to the initial value of the MAP.
ethanolic extract of the trunk bark of H. floribunda could 
have beneficial effects on the preventive treatment of CVD. 
Indeed, antioxidants have the ability to trap and inhibit the 
formation of free radicals. Flavonoids as antioxidants have 
effects on veins and arteries by decreasing permeability 
and increasing capillary resistance (23). It is known that 
the regular feeding of fruits and vegetables decreases the 
risk of developing CVD (25), as they contain antioxidants. 
According to the total polyphenols content and the 
screening study, the antioxidant properties might be 
mainly due to the presence of polyphenolic compounds 
such as tannins, flavonoids, and leuco-anthocyanins. 
Polyphenols are known as antioxidants and include five 
main families, namely phenolic acids, phenolic alcohols, 
flavonoids, tannins, and lignans (26). This work confirms 
that of Badmus et al (21) who showed that the leaves of 
H. floribunda possess antioxidant activity. Moreover, 
according to N’guessan et al (27), the anti-radical capacity 
is often correlated with the total polyphenols content of 
plant extracts. The result of the kinetics of the reduction 
obtained in the current study (Figure 4) is similar to those 
of Popovici et al (28). These observations show that the 
hydro-ethanolic extract of H. floribunda bark exhibited 
strong anti-radical efficiency. 
The fall in MAP was based on the administered dose 
(Figures 5 and 6). Intravenous injection of the hydro-
ethanolic extract of H. floribunda induced a significant 
decrease in DBP, in SBP, and thus in MAP. It should be 
noted that the dose of 40 mg/kg was seen as a best one 
(induce a better effect) because the return back effect 
under this dose is not only very slow but also weak. 
These results are somewhat similar to those obtained 
on the extracts of Bidens pilosa by Dimo et al (29) and 
Kouakou et al (30), and might be due to the presence of 
polyphenols, alkaloids, and saponosides in the current 
extract. The extract of H. floribunda therefore exhibits 
antihypertensive (hypothensive) effects, as shown in 
similar studies (12,31). Indeed, similar development 
has been obtained by Titrikou et al (12) on the extracts 
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of Biophytum petersianum and Etou et al (31) on the 
extracts of Lippia multiflora. Furthermore, the possible 
mechanisms involved in this positive effect (hypothensive) 
could be an inhibition of orthosympathetic activity or 
a decrease in oxidative stress. Indeed, an increase in 
oxidative stress is observed in hypertensive patients (32). 
The polyphenols content in this extract might play a key 
role in inhibiting the action of activated oxygen species. 
Moreover, the antidiabetic activity of H. floribunda (22) 
might also have positive preventive effects, by improving 
the insulin sensitivity.
Conclusion
This study showed the presence of various active 
phytochemical groups in the bark of the trunk and 
the leaves of H. floribunda specimen of the Zone IV 
of Togo. So, the phytochemical screening revealed 
alkaloids, tannins (catechics, gallic), flavonoids, leuco-
anthocyanins, saponosides, free quinones, anthrax C- 
and O-heterosides), reducing compounds, mucilages, 
cardiotonic heterosides, sterols, and terpenoids in 
the two parts of H. floribunda. The hydro-ethanolic 
extract of the trunk bark of H. floribunda exhibited in 
vitro antioxidant activity and in vivo antihypertensive 
effect. The two observations might prove the use of H. 
floribunda extract in traditional medicine against cardio-
cardiovascular diseases. However, further study might 
be envisaged in order to elucidate the mechanism of 
action of the observed effects. This could provide strong 
pharmacological arguments that converge in favor of the 
use of H. floribunda as an alternative treatment against 
high blood pressure (hypertension). In the same way, it 
might be very interesting to carry out a more thorough 
phytochemical study in the hope of isolating some active 
principles responsible for this hypotensive activity.
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